Abstract
It is estimated that in the United States during 1989, a total of 47100 patients will be diagnosed with bladder carcinoma (Silowberg and Lubera 1989). During this same year, a sizeable number of patients (approximately 10200) are expected to die from this disease. Unfortunately, despite recent advances in surgical and radiotherapeutic techniques, the percentage of patients dying from this disease has not changed since 1930. For superficial bladder carcinomas (stage 0, A, B1), acceptable locoregional control rates and 5-year survivals have been obtained with transurethral resection of the bladder, partial cystectomy, interstitial implants, and intravesicular chemotherapy. With deeply infiltrating tumors, a high incidence of lymphatic involvement significantly worsens the prognosis, whatever treatment modality is attempted. In the best reported series, surgery or definitive radiotherapy for invasive bladder carcinoma achieved only a 25%-30% survival rate (Pearse et al. 1978; Prout 1976; Richie et al. 1975).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bagshaw MA (1961) Possible role of potentiators in radiation therapy. AJR 85: 822–833
Batata MA, Chu FCH, Hilaris BS et al. (1981) Factors of prognostic and therapeutic significance in patients with bladder cancer. Int J Radiat Oncol Biol Phys 7: 575–579
Blandy JP, England HR, Evans ST et al. (1980) T3 bladder cancer: the case for salvage cystectomy. Br J Urol 52: 506–510
Bloom HJD, Henry W, Wallace D, Skeet R (1982) Treatment of T3 bladder cancer: a controlled trial of pre-operative radiotherapy and radical cystectomy vs. radical radiotherapy. Br J Urol 54: 136–151
Byfield JE, Barone R, Mendelsohn J et al. (1980) Infusional 5-FU and x-ray therapy for nonresectable esophageal cancer. Cancer 45: 703–708
Byfield JE, Calabro JP, Klisak I, Kulhanian F (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-FU and x-rays. Int J Radiat Oncol Biol Phys 8: 1923–1933
Cade IS, McEwen JB (1978) Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964–1976. Clin Radiol 29: 333–338
Chabner B (1982) Role of drugs in cancer treatment In: Chabner B (ed) Pharmacologic principles of cancer treatment. WB Saunders, Philadelphia, pp 3–14
Coffinet DR, Schneider MJ, Gladstein EJ et al. (1975) Bladder cancer: results of radiation therapy in 384 patients. Radiology 117: 149–153
Cummings BJ, Rieder WD, Hardwood AR et al. (1982) Combination radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canal. Cancer Treat Rep 66: 489–492
Goodman GB, Hislop TG, Elwood JM et al. (1982) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7: 569–573
Heidelberger C, Greisbach C, Montag BJ et al. (1958) Studies in fluorinated pyrimidin: II. Effects of transplanted tumor. Cancer Res 18: 305–317
John M, Flan M, Wittlinger P, Mowry PA (1987) Inoperable esophageal carcinoma: results of agressive synchronous radiotherapy. Am J Clin Oncol (CCT): 4: 310–316
Lockich JJ (1984) Infusion chemotherapy for cancer. Curr Concepts Oncol 6: 3–8
Marks LB, Kauffman SD, Prout GR Jr, Henry NM, Griffin EF, Shipley WU (1988) Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, up front MCV chemotherapy and pelvic irradiation plus cisplatinum. Int J Radiat Oncol Biol Phys 15: 877–883
Marshall VF (1952) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical tumors. J Urol 68: 714–723
Miller LS, Johnson DE (1972) Megavoltage irradiation for bladder cancer: Alone, postoperative, and preoperative? In: Proceedings of the National Cancer Conference. JB Lippincott, Philadelphia, pp 771–782
Murthy AK, Taylor WSG, Showeil J et al. (1987) Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. Int J Radiat Oncol Biol Phys 13; 1807–1813
Pearse DD, Reed RR, Hodges CV (1978) Radical cystectomy for bladder cancer. J Urol 119: 216–218
Prout GR Jr (1976) The surgical management of bladder carcinoma. Urol Clin North Am 3: 149–175
Richie JP, Skinner DG, Kaufman JJ (1975) Carcinoma of the bladder: treatment by radical cystectomy. J Surg Res 18: 217–75
Rotman M, Aziz H, Porrazzo, et al. (1990) Treatment of Advanced Transitional Cell Carcinoma of the Bladder with Irradiation and Concomitant 5-FU Infusion. Int J Radiation Oncology Biol Phys Vol 18, pp 1131–1137
RTOG 77–05/81–10 (1981) Phase I and II study, comparing the value of neutron alone, mixed beam and preoperative mixed in bladder carcinoma.
RTOG 81–05 (1981) Phase I/II study on the value of combining misonidazole and radiotherapy in the treatment of bladder cancer.
RTOG 83–08 (1982) Randomized phase II study to evaluate hyperfractionation radiation for locally advanced carcinoma of the bladder.
Russell KJ, Boileau MA, Ireton RC et al. (1988) Transitional cell carcinoma of the urinary bladder: histologic clearance with combined 5-FU chemotherapy and radiation therapy. Preliminary results of bladder preservation study. Radiology 167: 845–848
Sagerman RH, Veenema RJ, Guttmann R, Dean AL Jr, Uson AC (1968) Pre-operative irradiation of carcinoma of the bladder. Am J Roent Rad Ther Nucl Med 102: 577–580
Sagerman RH, Yo WS, Ryoo MC, King GA, Chung CT, Emanuel IG (1980) Int J Radiat Oncol Biol Phys 6: 607–612
Saur R, Schrott KM, Dunst J, Thiel HJ, Hermanek P, Bornhoff C (1988) Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cispla- tinum. Int J Radiat Oncol Biol Phys 15: 871–875
Scanion PW, Scott M, Sergura JW (1983) A comparison of short course, low dose, and long course, high dose preoperative radiation for carcinoma of the bladder. Cancer 52: 1153–1159
Seifert P, Baker CH, Reed ML (1975) Comparison of continuous infused 5-FU with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 36: 123–128
Shipley WU, Coombs LJ, Einstein AB Jr et al. (1984) Cisplatinum and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 132: 899–903
Silowberg E, Lubera JA (1989) Cancer Statistics, 1989. CA 39: 3–20
Stein JJ, Kaufman JJ (1968) Treatment of carcinoma of bladder with special reference to the use of preoperative radiation therapy combined with 5-FU. Am J Roent Rad Ther Nucl Med 102: 519–529
van der Werf-Messing G, Friedell GH, Menon RS, Hop WCJ, Wassif SB (1982) Carcinoma of the urinary bladder T2NXMO treated by pre-operative irradiation followed by cystectomy. Int J Radiat Oncol Biol Phys 8: 1849–1855
Vietti J, Eggerding F, Valeriote F (1971) Combined effect of radiation and 5-FU on survival of transplanted leukemia cells. JNCI 47: 865–870
Woodruff MW, Murphy WT, Hopson JM (1963) Further observation on the use of combination 5-FU and super- voltage irradiation therapy in treatment of advanced carcinoma of bladder. J Urol 90: 747–758
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rotman, M., Aziz, H., Potters, L., Choi, K. (1991). Treatment of Advanced Carcinoma of the Bladder with Concomitant 5-Fluorouracil Infusion and Radiation. In: Rotman, M., Rosenthal, C.J. (eds) Concomitant Continuous Infusion Chemotherapy and Radiation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84186-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-84186-6_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84188-0
Online ISBN: 978-3-642-84186-6
eBook Packages: Springer Book Archive